Pakistan To Purchase 1.2 Million Covid-19 Vaccine Doses From China's Sinopharm

China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday.

migrator

Published:31st Dec, 2020 at 11:27 AM

Islamabad

Pakistan will purchase 1.2 million COVID-19 vaccine doses from China’s Sinopharm, a minister said on Thursday.

“The Cabinet Committee has decided to initially purchase 1.2 million doses of the vaccine from the Chinese company Sinopharm, which will be provided free of cost to frontline workers in the first quarter of 2021,” Pakistani Minister for Science and Technology said on Twitter.

China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, its first approved shot for general public use.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Pakistan To Purchase 1.2 Million Covid-19 Vaccine Doses From China's Sinopharm

China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday.

Also Read

Red Fort blast: Delhi court allows accused woman doctor to meet advocate in NIA custody

US, Taiwan sign USD 250 billion trade deal, cutting tariffs on Taiwanese goods

Winter, pollution, changing lifestyle surging autoimmune diseases in women

"Vijay should understand that this accident happened only because of him": DMK spokesperson TKS Elangovan on Karur stampede incident

Tamil Nadu govt releases Rs 111.96 crore to farmers for crop damage